Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven E Feldon

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Experimental Eye Research|September 24, 2014
Mapracorat, a selective glucocorticoid receptor agonist, upregulates RelB, an anti-inflammatory nuclear factor-kappaB protein, in human ocular cellsSherry L Spinelli, Xia Xi, David H McMillan, et al.
Brain and Behavior|July 3, 2024
Vision-related quality of life after unilateral occipital strokeNeil Dogra, Bryan V Redmond, Selena Lilley, et al.
Plos One|September 19, 2019
The polyether ionophore salinomycin targets multiple cellular pathways to block proliferative vitreoretinopathy pathologyAlison M Heffer, Jacob Proaño, Elisa Roztocil, et al.
JAMA Neurology|April 24, 2014
The idiopathic intracranial hypertension treatment trial: clinical profile at baselineMichael Wall, Mark J Kupersmith, Karl D Kieburtz, et al.
JAMA|April 24, 2014
Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial, Michael Wall, Michael P McDermott, et al.
BMC Ophthalmology|November 23, 2006
Development and validation of a computerized expert system for evaluation of automated visual fields from the Ischemic Optic Neuropathy Decompression TrialSteven E Feldon, Lori Levin, Roberta W Scherer, et al.
The American Journal of Pathology|March 17, 2011
The aryl hydrocarbon receptor ligand ITE inhibits TGFβ1-induced human myofibroblast differentiationGeniece M Lehmann, Xia Xi, Ajit A Kulkarni, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|February 2, 2023
Evaluation of Optic Disc Edema in Long-Duration Spaceflight Crewmembers Using Retinal PhotographyWilliam E Valencia, Sara S Mason, Tyson J Brunstetter, et al.
The Journal of Clinical Endocrinology and Metabolism|June 30, 2023
Proof-of-concept and Randomized, Placebo-controlled Trials of an FcRn Inhibitor, Batoclimab, for Thyroid Eye DiseaseGeorge J Kahaly, Peter J Dolman, Jan Wolf, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Experimental Eye Research|September 24, 2014
Mapracorat, a selective glucocorticoid receptor agonist, upregulates RelB, an anti-inflammatory nuclear factor-kappaB protein, in human ocular cellsSherry L Spinelli, Xia Xi, David H McMillan, et al.
Brain and Behavior|July 3, 2024
Vision-related quality of life after unilateral occipital strokeNeil Dogra, Bryan V Redmond, Selena Lilley, et al.
Plos One|September 19, 2019
The polyether ionophore salinomycin targets multiple cellular pathways to block proliferative vitreoretinopathy pathologyAlison M Heffer, Jacob Proaño, Elisa Roztocil, et al.
JAMA Neurology|April 24, 2014
The idiopathic intracranial hypertension treatment trial: clinical profile at baselineMichael Wall, Mark J Kupersmith, Karl D Kieburtz, et al.
JAMA|April 24, 2014
Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial, Michael Wall, Michael P McDermott, et al.
BMC Ophthalmology|November 23, 2006
Development and validation of a computerized expert system for evaluation of automated visual fields from the Ischemic Optic Neuropathy Decompression TrialSteven E Feldon, Lori Levin, Roberta W Scherer, et al.
The American Journal of Pathology|March 17, 2011
The aryl hydrocarbon receptor ligand ITE inhibits TGFβ1-induced human myofibroblast differentiationGeniece M Lehmann, Xia Xi, Ajit A Kulkarni, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|February 2, 2023
Evaluation of Optic Disc Edema in Long-Duration Spaceflight Crewmembers Using Retinal PhotographyWilliam E Valencia, Sara S Mason, Tyson J Brunstetter, et al.
The Journal of Clinical Endocrinology and Metabolism|June 30, 2023
Proof-of-concept and Randomized, Placebo-controlled Trials of an FcRn Inhibitor, Batoclimab, for Thyroid Eye DiseaseGeorge J Kahaly, Peter J Dolman, Jan Wolf, et al.
Pageof 7